SEOUL, Jul. 12 (Korea Bizwire) — Samsung Electronics Co. said Friday it has participated in a Series D investment round for the U.S. biotech company Element Biosciences, Inc. as a strategic investor, expecting to create synergy in the potential medical and digital health care sectors. Samsung Electronics joins other investors, including Fidelity and Foresite Capital, [...]
SEOUL, Jun. 27 (Korea Bizwire) – South Korean vaccine developers are leveraging the expertise gained during COVID-19 vaccine development to accelerate the creation of messenger RNA (mRNA) vaccine platforms. This push has gained momentum following the Korea Disease Control and Prevention Agency’s recent emphasis on domestically producing mRNA vaccine platforms capable of developing vaccines within 100-200 [...]
SEOUL, Jun. 8 (Korea Bizwire) –As the United States Congress deliberates the Biosecure Act, which would prohibit federal agencies from dealing with certain Chinese biotech companies, South Korean pharmaceutical contract development and manufacturing organizations (CDMOs) are seizing the chance to attract new clients. The proposed legislation, which has reached the House floor for a full [...]
SEOUL, Mar. 15 (Korea Bizwire) – The South Korean government is gearing up to disclose a report by year-end that will reveal the financial benefits received by doctors from pharmaceutical companies, sparking a debate on whether to include identifiable information such as names in the report. According to a statement from the Ministry of Health and [...]
SEOUL, Feb. 29 (Korea Bizwire) – Amid a worldwide shake-up of industrial sectors, Korean firms are experiencing a range of emotions about the future of their key operations, feelings that vary widely depending on the size of the business and the industry it belongs to. A recent survey conducted by the Korea Chamber of Commerce and [...]
WOBURN, Mass. and NEW YORK, Jan. 22, 2024 (Korea Bizwire) – Abpro Corporation (“Abpro”), a biotech company with the mission of improving the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies, and Atlantic Coastal Acquisition Corp. II (NASDAQ: ACAB), a special purpose acquisition company (“Atlantic Coastal”), today announced the filing of [...]
Potential First-in-Class Novel Molecule with Novel Target In-Licensed from Collaboration with Bayer SALT LAKE CITY, Jan. 04, 2024 (Korea Bizwire) – Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced it has signed an agreement with Bayer AG to in-license a new chemical entity that emerged from the companies’ [...]
PARIS, Nov. 16, 2023 (Korea Bizwire) – Curium, a world leader in nuclear medicine, announced today that in partnership with its exclusive distributor SYN Innovation Laboratories in Greece, the first patients in Greece have been injected with PYLCLARI® (INN: Piflufolastat (18F) also known as (18 F)-DCFPyL, indicated for the detection of prostate-specific membrane antigen (PSMA) positive lesions [...]
SHANGHAI, China, Nov. 07, 2023 (Korea Bizwire) – Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, opens the ChinaTrials 15 conference in Shanghai, China with a message to China biotechs about the benefits of conducting simultaneous China, US and Australia trials to accelerate drug development. (November 8-10, 2023) Novotech is commencing this significant summit [...]
SEOUL, Oct. 30 (Korea Bizwire) – The pharmaceutical and biotechnology industry is making significant strides in enhancing its presence in the beauty sector, particularly in the realm of cosmetics. Industry experts suggest that this strategic shift is aimed at attracting consumers and driving sales by emphasizing pharmaceutical companies’ focus on health. In recent developments, the Yuhan [...]